Susquehanna International Group’s HeartSciences Inc Warrant HSCSW Stock Holding History

Susquehanna International Group’s Portfolio HSCSW Stock Details HSCSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-38,517	Closed	-$3.52K	–	13040
2025 Q2	$3.52K	Buy	38,517 +8,388	+28%	+$611	﹤0.01%	12463
2025 Q1	$1.21K	Sell	30,129 -10,406	-26%	-$460	﹤0.01%	12317
2024 Q4	$1.22K	Buy	40,535 +1,711	+4%	+$64	﹤0.01%	12045
2024 Q3	$1.7K	Buy	38,824 +7,865	+25%	+$332	﹤0.01%	11795
2024 Q2	$1.52K	Buy	+30,959	New	+$1.17K	﹤0.01%	11858
2023 Q1	–	Sell	-25,482	Closed	-$6.94K	–	12961
2022 Q4	$6.94K	Buy	+25,482	New	+$8.5K	﹤0.01%	11997

Other funds holding HSCSW

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's HSCSW Position: Q3 2025 in Review

Susquehanna International Group sold out of HeartSciences Inc Warrant (HSCSW) in Q3 2025, closing a stake of 38,517 shares — an estimated $3.52K sold.

Susquehanna International Group first reported a position in HSCSW in Q4 2022 and held it in 6 quarters. The position peaked at $6.94K in Q4 2022. 3 funds tracked by Wall St. Rank hold HSCSW as of Q3 2025.

Susquehanna International Group reported no remaining HeartSciences Inc Warrant position as of Q3 2025 after selling out during the quarter.
Susquehanna International Group sold 38,517 HeartSciences Inc Warrant shares in Q3 2025, an estimated $3.52K.
Susquehanna International Group first reported a position in HeartSciences Inc Warrant in Q4 2022 and held it in 6 quarters.
Susquehanna International Group's HeartSciences Inc Warrant position peaked at $6.94K in Q4 2022.
3 funds tracked by Wall St. Rank held HeartSciences Inc Warrant as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.